Document:

Prepared by MerrillDirect

EXHIBIT 4.35

EXECUTION COPY

SECOND FORBEARANCE AGREEMENT

             THIS
SECOND FORBEARANCE AGREEMENT (this “Agreement”) is entered into as of
August 31, 2001 among LEINER HEALTH PRODUCTS INC. (the “U.S. Borrower”),
VITA HEALTH PRODUCTS INC. (the “Canadian Borrower,” and together with
the U.S. Borrower, the “Borrowers”), THE BANK OF NOVA SCOTIA, as U.S.
Agent and as Canadian Agent, and the lenders party to the Credit Agreement
referred to below.

RECITALS

             A.         Pursuant to that certain Amended and
Restated Credit Agreement, dated as of May 15, 1998 (as further amended,
supplemented, amended and restated or otherwise modified prior to the date
hereof, the “Credit Agreement”; capitalized terms used but not defined
herein shall have the meanings given them in the Credit Agreement), the Agents
and the Lenders made Loans and other financial accommodations to the Borrowers.

             B.          The following Defaults or Events of
Default (the “Existing Defaults”) exist under the Credit Agreement:

                           1.          The failure of the Borrowers to comply
with each of the financial covenants set forth in Section 9.2.4 of the Credit
Agreement as of or for the Fiscal Quarters ending December 31, 2000, March 31,
2001, and June 30, 2001; and

                           2.          The Borrowers’ breach of the
representations, warranties and statements contained in the Loan Documents in
connection therewith.

             C.          On or about June 29, 2001, the
Borrowers, the Agents and the Lenders entered into a forbearance agreement (the
“First Forbearance Agreement”) pursuant to which the Agents and the Lenders
agreed to forbear with respect to their rights or remedies against the
Borrowers based on the Existing Defaults until September 1, 2001 and agreed
that the forbearance period would be automatically extended if the Borrowers
met certain conditions set forth in Section 1(b) of the First Forbearance
Agreement.

             D.         The Borrowers, the Agents and the
Lenders are continuing to discuss the terms of a restructuring of the
Borrowers’ indebtedness and liabilities, and the Borrowers have requested that
the Required Lenders extend their forbearance on the terms and conditions set
forth below.

             E.          The Required Lenders are willing to
forbear from exercising their rights and remedies in connection with the
Existing Defaults on the terms and conditions set forth herein.

AGREEMENT

             In
consideration of the Recitals and of the mutual promises and covenants
contained herein, the Borrowers, the Agents and the Required Lenders agree as
follows:

             Section
1.  Agreement to Forbear.

                           (a)
        Forbearance. 
During the period (the “Forbearance Period”) commencing on the
date hereof and ending on the earlier to occur of September 28, 2001 and the
date of any Forbearance Default (as defined below), and subject to the
satisfaction of the conditions set forth in Section 2 hereof, the Agents and
the Lenders will forbear from exercising their rights and remedies under the
Credit Agreement and the other Loan Documents solely with respect to the
Existing Defaults.  “Forbearance
Default” shall mean: (i) an Event of Default (other than the Existing
Defaults), (ii) the failure of either Borrower to keep or perform any of the
covenants or agreements contained herein providing for a payment or prepayment
to the Agents or the Lenders, (iii) the failure of either Borrower to keep or
perform any of the covenants or agreements contained herein (other than those
referred to in clause (ii) above) two Business Days after the date the
Borrowers receive written notice from an Agent of any such failure (the “Notice
Period”), provided that in the event any such failure is remedied
within the Notice Period, such failure shall not constitute a Forbearance
Default, (iv) any representation or warranty of either Borrower herein shall be
incorrect when made or deemed made in any material respect, (v) negotiations
between the Borrower and the potential equity investor in the Borrower
terminate without the issuance of a commitment letter or (vi) negotiations
between the U.S. Borrower and the holders of the U.S. Borrower’s 9-5/8% Senior
Subordinated Notes due 2007 (the “Notes”) terminate without agreement on
a term sheet for the treatment of the Notes.

                           (b)
       Nature of the Forbearance.  The forbearance set forth herein is limited and shall not be
deemed (i) a waiver of any Default or Event of Default, including the Existing
Defaults, which now exist or may hereafter arise, (ii) a forbearance with
respect to any term, condition or obligation of the Borrowers in the Credit
Agreement or any other Loan Document other than the Existing Defaults, (iii) a
waiver of any of the conditions precedent to Credit Extensions contained in
Section 7.2 of the Credit Agreement or (iv) subject to the terms contained
herein, to prejudice any right or remedy which any Agent or any Lender may now
or in the future have under or in connection with the Credit Agreement or any
other Loan Document.

             Section
2.  Conditions Precedent to
Effectiveness of Agreement.  This Agreement shall not be
effective unless and until each of the following conditions shall have been
satisfied in the sole discretion of the Agents:

                           (a)
        The Agents shall have received (i)
counterparts of this Agreement duly executed by each of the Borrowers and the
Required Lenders and (ii) an Affirmation and Consent, in form and substance
satisfactory to the Agents, duly executed by each of the Guarantors.

                           (b)
       The Agents shall have received, for
the pro rata benefit of the Lenders executing this Agreement on or before
September 7, 2001 (the “Consenting Lenders”), a forbearance fee of
$300,000, which shall be fully earned when paid and nonrefundable.

                           (c)
        The Borrowers shall have deposited
in immediately available funds with (i) the U.S. Agent, $1,958,052.80
representing interest that will accrue on the Credit Extensions under the U.S.
Facility (calculated based on the U.S. Alternate Base Rate as in effect on the
date hereof and as increased hereunder) and (ii) the Canadian Agent,
Cdn.$315,877.86, representing interest that will accrue on the Credit
Extensions under the Canadian Facility (calculated based on the Canadian Prime
Rate as in effect on the date hereof and as increased hereunder), in each case
for October 2001.  The foregoing
payments shall be held in escrow on terms satisfactory to the applicable Agent
and shall be applied by the applicable Agent to the monthly payment of interest
on the applicable Credit Extensions for October 2001.

                           (d)
       The Agents shall have been
reimbursed for the unpaid fees and expenses incurred through the date hereof of
its professionals, including the unpaid fees and expenses of Luskin, Stern
& Eisler LLP, PricewaterhouseCoopers LLP, Casas, Benjamin & White, LLC
(“CBW”) and Hunton & Williams.

             Section
3.  Representations and Warranties.  The
Borrowers hereby represent and warrant to the Agents and to the Lenders as
follows:

                           (a)
        Recitals.  The
Recitals in this Agreement are true and correct in all respects.

                           (b)
       Incorporation of Representations and Statements.  All statements of the Borrowers contained in
Section 7.2.1 of the Credit Agreement, and all representations and warranties
of the Borrowers in the Credit Agreement and the other Loan Documents, are
incorporated herein in full by this reference and are, other than with respect
to the Existing Defaults, true and correct as of the date hereof in all
material respects.

                           (c)
        Power; Authorization. 
Each of the Borrowers has the corporate power, and has been duly
authorized by all requisite corporate action, to execute and deliver this
Agreement and to perform its obligations hereunder.  This Agreement has been duly executed and delivered by the
Borrowers.

                           (d)
       Enforceability. 
This Agreement is the legal, valid and binding obligation of each of the
Borrowers, enforceable against them in accordance with its terms.

                           (e)
        No Violation.  The
execution, delivery and performance of this Agreement does not and will not (i)
violate any law, rule, regulation or court order to which either of the
Borrowers is subject, (ii) conflict with or result in a breach of any Organic
Document of the Borrowers or any agreement or instrument to which either of the
Borrowers is party or by which it or its properties are bound, or (iii) result
in the creation or imposition of any Lien, security interest or encumbrance on
any property of either of the Borrowers, whether now owned or hereafter
acquired, other than liens in favor of the Agents.

                           (f)
        Obligations.  As of
the date hereof the outstanding principal balance of the U.S. Revolving Loans
is $90,867,415.83; U.S. Letter of Credit Outstandings is $11,902,372 (of which
$1,600,000 is cash collateralized under the terms of a Cash Collateral
Agreement dated as of April 16, 2001); Term B Loans is $65,295,196.41; Term C
Loans is $62,437,081.93; Term D Loans is $29,329,342.26; Canadian Revolving
Loans is Cdn.$28,739,530; Canadian Swingline Loans is Cdn.$230,000; and
Canadian Term Loans is Cdn.$16,587,824.21. 
Interest and fees have accrued thereon as provided in the Credit
Agreement and the other Loan Documents. 
The obligation of the Borrowers to repay the Loans, together with all
interest and fees accrued thereon, and the other Obligations is absolute and
unconditional, and there exists no right of set off or recoupment, counterclaim
or defense of any nature whatsoever to payment of the Obligations.

             Section
4.  Covenants of Borrowers.  The
Borrowers agree as follows:

                           (a)
        Forecasts.  By no
later than 4:00 p.m. on the second Business Day of each week, the Borrowers
will deliver to the Agents updated weekly rolling cash flow forecasts for the
following twelve week period, together with an actual to forecast variance
analysis for the preceding week, which forecasts shall also include a
certification from an Authorized Officer of the U.S. Borrower representing to
the information required pursuant to paragraph (c) below.

                           (b)
       U.S. Balance Sheets. 
Within 30 days after the end of each month, the Borrowers will deliver
to the Agents consolidated and consolidating balance sheets of the U.S.
Borrower and its Subsidiaries (including consolidating balance sheets of the
Canadian Borrower and its Subsidiaries) as of the end of such month, and consolidated
and consolidating statements of earnings and cash flow of the U.S. Borrower and
its Subsidiaries (including consolidating statements of earnings and cash flow
of the Canadian Borrower and its Subsidiaries) for such month and for the
period commencing at the end of the previous Fiscal Year and ending with the
last day of such month.

                           (c)
        Disbursements, etc.  The Borrowers will not permit cumulative (from July 1, 2001)
disbursements for all applicable months, as set forth in the Borrowers’ June 27,
2001 rolling 13-week forecast, as may be revised with the approval of CBW (the
“Forecast”), to exceed 110% of the cumulative (from July 1, 2001)
amounts set forth therefor in the Forecast and will not permit the cash balance
(inclusive of amounts escrowed for October 2001 interest under Section 2(c)
hereof) at the end of any month to be less than 90% of the cash balance set
forth in the Forecast for such month. 
The Borrowers agree that all payments or disbursements to an Affiliate
or employee of a Borrower (including Severance Payments (as defined below))
inconsistent with the Forecast or which are otherwise outside of the ordinary
course of business must be approved in advance by David Coles.

                           (d)
       Cooperation.  The
Borrowers agree to cooperate fully with the Agents, the Lenders and their
professionals, including in connection with any audit or appraisal of the
business, assets or financial condition of the Borrowers and their
Subsidiaries, in all cases at the Borrowers’ expense.

                           (e)
        Payment of Fees. 
In addition to and not in limitation of the terms of Section 12.3 of the
Credit Agreement, the Borrowers agree to pay on demand all reasonable fees and
expenses of (i) the Agents and all professionals retained by the Agents or by
Luskin, Stern & Eisler LLP (including special counsel engaged to review
various litigation issues), and (ii) each Lender (other than the legal fees of
each Lender expressly excepted from payment under Section 12.3 of the Credit
Agreement), in each case incurred in connection with the Credit Agreement or
this Agreement and the matters contemplated hereby and the restructuring of the
Obligations, and whether incurred prior to or subsequent to the date hereof.

                           (f)
        Bank Accounts. 
Neither the Borrowers nor any of their Subsidiaries will maintain any
checking, savings or other account at any bank or other financial institution,
or any other account where money or securities may be deposited or maintained,
other than the accounts specified in the Amended and Restated Perfection Certificate
dated as of June 15, 2001.

                           (g)
       Suspension of Commitments.  The Commitments are suspended.

                           (h)
       LIBOR Restrictions. 
The outstanding principal amount of the Loans may not be continued as,
or converted into, LIBO Rate Loans or Canadian BAs, as applicable.

                           (i)
         Increased Interest. 
The Applicable Margin shall in each case be increased by 1% over that
otherwise in effect in accordance with the terms of the Credit Agreement.

                           (j)
         Restrictions on Indebtedness, Etc.  The Borrowers and their Subsidiaries are
prohibited from incurring Indebtedness under clauses (d), (g), (h) or (l) of
Section 9.2.2 of the Credit Agreement; making Investments under clauses (f),
(i) or (j) of Section 9.2.5 of the Credit Agreement; redeeming shares of
Capital Stock under clause (iii) of the proviso to Section 9.2.6 of the Credit
Agreement; consummating acquisitions or mergers under clauses (b), (c) or (d)
of Section 9.2.10 of the Credit Agreement; or paying any fees under clause (b)
of Section 9.2.13 of the Credit Agreement.

                           (k)
        Monthly Payment of Interest and Fees.  All interest for Base Rate Loans and
Canadian Prime Rate Loans, and all Letter of Credit fees payable under Section
5.3.3 of the Credit Agreement, shall be payable in arrears on the fifteenth day
of each month (instead of the Quarterly Payment Dates).

                           (l)
         Canadian Balance Sheets. 
Within 21 days after the end of each month, the Canadian Borrower will
deliver to the Canadian Agent consolidated and consolidating balance sheets of
the Canadian Borrower and its Subsidiaries as of the end of such month and
consolidated statements of earnings and cash flow of the Canadian Borrower and
its Subsidiaries for such month and for the period commencing at the end of the
previous Fiscal Year and ending with the last day of such month.

                           (m)
       Intercompany Dispositions.  The U.S. Borrower and its U.S. Subsidiaries will not, directly or
indirectly, make any Investments (including intercompany loans or capital
contributions) in or to the Canadian Borrower or any of the Canadian Borrower’s
Subsidiaries, or sell, transfer, lease, contribute or otherwise convey
(including by way of merger), or grant options, warrants or other rights (all
collectively referred to as a “Disposition”) with respect to all or any
part of their assets to the Canadian Borrower or any of the Canadian Borrower’s
Subsidiaries other than in the ordinary course of business consistent with past
practices.  The Canadian Borrower and
its Subsidiaries will not, directly or indirectly, make any Investments (including
intercompany loans or capital contributions) in or to (or pay dividends or make
distributions to) the U.S. Borrower or any of the U.S. Borrower’s U.S.
Subsidiaries, or make any Disposition with respect to all or any part of their
assets to the U.S. Borrower or any of the U.S. Borrower’s U.S. Subsidiaries,
other than in the ordinary course of business consistent with past practices.

                           (n)
       Restrictions on Reallocation of Commitments.  The Borrowers’ right to reallocate the
unused Canadian Revolving Loan Commitment Amount and the unused U.S. Revolving
Loan Commitment Amount pursuant to, respectively, Sections 2.2.3 and 3.2.2 of
the Credit Agreement is suspended.

                           (o)
       Antitrust Proceeds. 
Unless otherwise agreed to by the Required Lenders, including as to
amount and application, concurrently with the receipt by either of the
Borrowers or any of their Affiliates of any judgment, settlement or other
proceeds or amounts, however characterized (with all of the foregoing
collectively referred to as the “Proceeds”), arising from or in
connection with any antitrust claims (the “Claims”) (including claims
pending in (i) the United States District Court for the Central District of
California styled Leiner Health Products Inc. v. F. Hoffman-LaRoche Ltd., et
al., Case No. 99-09832-JSL and (ii) the United States District Court for
the District of Columbia entitled In Re Vitamins Antitrust Litigation,
MDL No. 1285, Misc. No. 99-0197, and all facts and circumstances at issue
therein), the U.S. Borrower shall make, or cause to be made, a mandatory
prepayment of the Loans in the amount of such Proceeds (with such prepayment
being applied to the remaining Term Loan amortization payments pro rata
in accordance with the amount of each such remaining Term Loan amortization payment)
and the cash collateralization of all Letters of Credit and a corresponding
reduction of each Revolving Loan Commitment Amount.  The Borrowers reaffirm and ratify the perfected security interest
in the Claims and Proceeds of the Agents and the Lenders.

                           (p)
       Restructuring.  The
Borrowers will report to the Agents on a weekly basis with respect to the
status of their negotiations with the potential equity investor in the
Borrowers and the holders of the Notes. 
The Borrowers agree to continue to negotiate a restructuring of their
indebtedness and liabilities in good faith with the Agents and the Lenders.

                           (q)
       Chief Operating Officer. 
The U.S. Borrower agrees to hire a chief operating officer of the U.S.
Borrower (the “COO”) who shall be reasonably satisfactory to the Agents
and use good faith efforts to complete such hiring on or before October 15,
2001.  The Borrowers shall provide the
Agents and CBW with access to the executive search firm retained in connection
with the COO search process and will direct such firm to fully cooperate with
the Agents and CBW regarding all reasonable requests for information or
documentation in connection therewith. 
The Borrowers will continue to work in good faith with the Agents and
their professionals to refine the description of the required qualifications,
capabilities, role and authority of the COO position.

                           (r)
        Severance Agreements. 
The Borrowers shall not enter into any severance agreement (a “Severance
Agreement”) with, or similar arrangement providing for the payment of money
or other consideration (a “Severance Payment”) to, any current or former
employee in connection with the termination (under any circumstances) of such
employee’s employment with a Borrower without the Agents’ prior written consent,
which shall not be unreasonably withheld or delayed, provided that a
Borrower may enter into a Severance and Release Agreement (a “Release”)
which is contemplated by and executed in connection with a Severance Agreement
existing on the date hereof, so long as such Release does not expand the rights
of any employee under the related Severance Agreement.  The Borrowers will promptly deliver to the
Agents copies of all Releases reasonably requested by the Agents or CBW and
will not make any Severance Payments or enter into any Release without first
providing 5 Business Days’ prior written notice to the Agents.  The Borrowers will not make any
discretionary non-contractual Severance Payments without the Agents’ prior written
consent.

                           (s)
        Net Disposition Proceeds. 
The Borrowers agree that notwithstanding anything to the contrary
contained in the second sentence of the definition of “Net Disposition
Proceeds” in the Credit Agreement, Net Disposition Proceeds shall exclude only
an aggregate amount equal to $500,000 of proceeds of Permitted Dispositions
received on or after July 1, 2001 through and until the termination of the
Forbearance Period, provided that the proceeds of (i) any Permitted
Disposition resulting in proceeds of less than $50,000 and (ii) the sale of
Obsolete Inventory (as defined below), shall also be excluded from Net
Disposition Proceeds and shall not be counted toward the $500,000 basket.  “Obsolete Inventory” shall mean
inventory for which the U.S. Borrower took an inventory reserve for Fiscal Year
2001 or which comprises part of a discontinued product line, other than
inventory transferred in connection with a sale of all of the stock, all or
substantially all of the assets, or a division or other similar operating or
administrative unit of a Borrower or a Subsidiary or Affiliate of a
Borrower.  As part of the second weekly
rolling cash flow forecast for any month, the U.S. Borrower shall deliver to
the Agents, with respect to the prior month, a report certified by David Coles,
of the sales value, standard cost and inventory reserve associated with the
Obsolete Inventory sold in such month.

                           (t)
        Continued Compliance with Loan Documents.  Each of the Borrowers will continue to
comply with all of its covenants and other obligations under the Credit
Agreement and the other Loan Documents.

The provisions contained in paragraphs
(a), (c), (d), (f), (i), (o), (r) and (s) above shall continue to and including
the date of termination of the Forbearance Period (and shall terminate on such
date) and the provisions contained in paragraphs (b), (e), (g), (h), (j), (k),
(l), (m), (n), (p), (q) and (t) shall survive termination of the Forbearance
Period.  Nothing in this Agreement,
including paragraph 4(s) or the termination thereof, shall prejudice or otherwise
affect the right of any party to argue that the sale of Obsolete Inventory by a
Borrower does or does not constitute a Permitted Disposition or that the
proceeds of any such sale do or do not constitute Net Disposition Proceeds, and
no party shall assert in any proceeding or other context that terms of
paragraph 4(s) or the termination thereof are relevant to any such argument.

             Section
5.  Effect and Construction of
Agreement.  Except as expressly provided herein, the
Credit Agreement and the other Loan Documents shall remain in full force and
effect in accordance with their respective terms, and this Agreement shall not
be construed to:

                           (a)
        impair the validity, perfection or
priority of any Lien or security interest securing the Obligations;

                           (b)
       waive or impair any rights, powers
or remedies of any Agent or any Lender under the Credit Agreement or any other
Loan Document upon termination of the Forbearance Period, with respect to the
Existing Defaults or otherwise;

                           (c)
        constitute an agreement by any
Agent or any Lender or to require any Agent or any Lender to extend the
Forbearance Period, or grant additional forbearance periods, or extend the term
of the Credit Agreement or the time for payment of any of the Obligations; or

                           (d)
       require any Lender to make any
Loans or other extensions of credit to the Borrower.

In the event of any inconsistency between
the terms of this Agreement and the Credit Agreement or any of the other Loan
Documents, this Agreement shall govern. 
The Borrowers acknowledge that they have consulted with counsel and with
such other experts and advisors as they have deemed necessary in connection
with the negotiation, execution and delivery of this Agreement.  This Agreement shall be construed without
regard to any presumption or rule requiring that it be construed against the
party causing this Agreement or any part hereof to be drafted.

             Section 6.  Reference to and Effect on the Loan
Documents.

                           (a)
        Upon the effectiveness hereof,
each reference in the Credit Agreement to “this Agreement,” “hereunder,”
“hereof” or words of like import referring to the Credit Agreement, and each
reference in the other Loan Documents to the Credit Agreement, “thereunder,”
“thereof” or words of like import referring to the Credit Agreement, shall mean
and be a reference to the Credit Agreement, as amended hereby.

                           (b)
       This Agreement shall be a Loan
Document.

             Section
7.  Miscellaneous.

                           (a)
        Further Assurances. 
The Borrowers agree to execute such other and further documents and
instruments as the Agents may request to implement the provisions of this
Agreement.

                           (b)
       Benefit of Agreement. 
This Agreement shall be binding upon and inure to the benefit of and be
enforceable by the parties hereto and their respective successors and assigns.  No other person or entity shall be entitled
to claim any right or benefit hereunder, including, without limitation, the
status of a third-party beneficiary of this Agreement.

                           (c)
        Integration.  This
Agreement, together with the Credit Agreement and the other Loan Documents,
constitutes the entire agreement and understanding among the parties relating
to the subject matter hereof, and supersedes all prior proposals, negotiations,
agreements and understandings relating to such subject matter.  In entering into this Agreement, the
Borrowers acknowledge that they are relying on no statement, representation,
warranty, covenant or agreement of any kind made by any Agent, any Lender or
any employee or agent of any Agent or any Lender, except for the agreements of
the Agents and the Lenders set forth herein.

                           (d)
       Severability.  The
provisions of this Agreement are intended to be severable.  If any provision of this Agreement shall be
held invalid or unenforceable in whole or in part in any jurisdiction, such
provision shall, as to such jurisdiction, be ineffective to the extent of such
invalidity or enforceability without in any manner affecting the validity or
enforceability of such provision in any other jurisdiction or the remaining
provisions of this Agreement in any jurisdiction.

                           (e)
        Counterparts; Telecopied Signatures.  This Agreement may be executed in any number
of counterparts and by different parties to this Agreement on separate
counterparts, each of which, when so executed, shall be deemed an original, but
all such counterparts shall constitute one and the same agreement.  Any signature delivered by a party by
facsimile transmission shall be deemed to be, and effective as, an original
signature hereto.

                           (f)
        Notices.  Any
notices with respect to this Agreement shall be given in the manner provided
for in Section 12.2 of the Credit Agreement.

                           (g)
       Survival.  Except
as otherwise provided herein, all representations, warranties, covenants,
agreements, undertakings, waivers and releases of the Borrowers contained
herein shall survive the termination of the Forbearance Period.

                           (h)
       Amendment.  No
amendment, modification, rescission, waiver or release of any provision of this
Agreement shall be effective unless the same shall be in writing and signed by
the Borrowers, the Agents and the Required Lenders.

             Section
8.  RELEASE OF CLAIMS.  EACH
OF THE BORROWERS HEREBY ACKNOWLEDGES AND AGREES THAT IT DOES NOT HAVE ANY
DEFENSES, COUNTERCLAIMS, OFFSETS, CROSS-CLAIMS, CLAIMS OR DEMANDS OF ANY KIND
OR NATURE WHATSOEVER THAT CAN BE ASSERTED TO REDUCE OR ELIMINATE ALL OR ANY
PART OF THE LIABILITY OF THE BORROWERS TO REPAY ANY AGENT OR ANY LENDER AS
PROVIDED IN THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS OR TO SEEK
AFFIRMATIVE RELIEF OR DAMAGES OF ANY KIND OR NATURE FROM ANY AGENT OR ANY
LENDER.  EACH OF THE BORROWERS HEREBY
VOLUNTARILY AND KNOWINGLY RELEASES AND FOREVER DISCHARGES THE AGENTS AND THE
LENDERS, AND EACH AGENT’S AND LENDER’S PREDECESSORS, AGENTS, EMPLOYEES,
CONSULTANTS, ADVISORS, ATTORNEYS, SUCCESSORS AND ASSIGNS, FROM ALL POSSIBLE
CLAIMS, DEMANDS, ACTIONS, CAUSES OF ACTION, DAMAGES, COSTS, EXPENSES, AND
LIABILITIES WHATSOEVER, KNOWN OR UNKNOWN, ANTICIPATED OR UNANTICIPATED,
SUSPECTED OR UNSUSPECTED, FIXED, CONTINGENT, OR CONDITIONAL, AT LAW OR IN
EQUITY, ORIGINATING IN WHOLE OR IN PART ON OR BEFORE THE DATE THIS AGREEMENT IS
EXECUTED, WHICH THE BORROWERS MAY NOW OR HEREAFTER HAVE AGAINST ANY SUCH AGENT
OR LENDER, AND SUCH AGENT’S OR LENDER’S PREDECESSORS, AGENTS, EMPLOYEES,
CONSULTANTS, ADVISORS, ATTORNEYS, SUCCESSORS AND ASSIGNS, IF ANY, AND
IRRESPECTIVE OF WHETHER ANY SUCH CLAIMS ARISE OUT OF CONTRACT, TORT, VIOLATION
OF LAW OR REGULATIONS, OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, THE
EXERCISE OF ANY RIGHTS AND REMEDIES UNDER THE CREDIT AGREEMENT OR OTHER LOAN
DOCUMENTS, AND NEGOTIATION AND EXECUTION OF THIS AGREEMENT.

             Each of
the Borrowers acknowledges and agrees that it understands the meaning and
effect of Section 1542 of the California Civil Code which provides:

“A
general release does not extend to claims which the creditor does not know or
suspect to exist in his favor at the time of executing the release, which if
known by him must have materially affected his settlement with the debtor.”

EACH OF THE BORROWERS AGREES TO ASSUME THE
RISK OF ANY AND ALL UNKNOWN, UNANTICIPATED OR MISUNDERSTOOD DEFENSES, CLAIMS,
CONTRACTS, LIABILITIES, INDEBTEDNESS AND OBLIGATIONS WHICH ARE RELEASED, WAIVED
AND DISCHARGED BY THIS AGREEMENT.  EACH
OF THE BORROWERS HEREBY WAIVES AND RELINQUISHES ALL RIGHTS AND BENEFITS WHICH
IT MIGHT OTHERWISE HAVE UNDER THE AFOREMENTIONED SECTION 1542 OF THE CALIFORNIA
CIVIL CODE OR ANY SIMILAR LAW, TO THE EXTENT SUCH LAW MAY BE APPLICABLE, WITH
REGARD TO THE RELEASE OF SUCH UNKNOWN, UNANTICIPATED OR MISUNDERSTOOD DEFENSES,
CLAIMS, CONTRACTS, LIABILITIES, INDEBTEDNESS AND OBLIGATIONS.  TO THE EXTENT THAT SUCH LAWS MAY BE
APPLICABLE, EACH OF THE BORROWERS WAIVES AND RELEASES ANY RIGHT OR DEFENSE
WHICH IT MIGHT OTHERWISE HAVE UNDER ANY OTHER LAW OF ANY APPLICABLE JURISDICTION
WHICH MIGHT LIMIT OR RESTRICT THE EFFECTIVENESS OR SCOPE OF ANY OF THEIR
WAIVERS OR RELEASES HEREUNDER.

             Section
9.  GOVERNING LAW; JURISDICTION;
WAIVER OF JURY TRIAL.  THIS AGREEMENT SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK.  THE JURISDICTIONAL, VENUE AND SERVICE OF
PROCESS PROVISIONS IN SECTION 12.14 OF THE CREDIT AGREEMENT AND THE JURY TRIAL
WAIVER IN SECTION 12.15 OF THE CREDIT AGREEMENT SHALL APPLY TO ANY SUIT, ACTION
OR PROCEEDING RELATED TO THIS AGREEMENT.

             IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written.

	 	LEINER
  HEALTH PRODUCTS INC.
	 	 	 
	 	 	 
	 	By:	 
	 	 	

	 	 	Name:
  
	 	 	Title:
	 	 	 
	 	 	 
	 	VITA
  HEALTH PRODUCTS INC.
	 	 
	 	 
	 	By:	 
	 	 	

	 	 	Name:
  
	 	 	Title:
	 	 	 
	 	 	 
	AGREED
  TO AND ACCEPTED	 	 
	AS
  OF THE DATE FIRST	 	 
	ABOVE
  WRITTEN:	 	 
	 	 	 
	THE
  BANK OF NOVA SCOTIA	 	 
	As
  Canadian Agent and a Lender	 	 
	 	 	 
	By:	 	 
	 	

	 
	 	Name:	 
	 	Title:	 
					

 

 

	AGREED
  TO AND ACCEPTED	 	 
	AS
  OF THE DATE FIRST	 	 
	ABOVE
  WRITTEN:	 	 
	 	 	 
	THE
  BANK OF NOVA SCOTIA,	 	 
	as
  the U.S. Agent and a Lender	 	 
	 	 	 
	By:	 	 
	 	

	 
	 	Name:	 
	 	Title:Ex. 10.9 for BIFS Technologies

Exhibit 10.9
                                     FORM OF
                                    AGREEMENT
                        BETWEEN HARDING ASSET FUNDS, INC.
                         AND BIOFILTRATION SYSTEMS, INC.
                                   TO PURCHASE
                           REMAINING 625,000 SHARES OF
                                A 504-D OFFERING

On March 31, 1999, Biofiltration Systems, Inc. (BIFS) agreed to sell 875,000
shares of its common stock to an entity called The Baldridge Group. The stock
was sold on a conditional sales contract. Baldridge brought in other partners to
purchase some of the stock. On September 1, 1999 BIFS was de-listed from the OTC
BB. Baldridge decided at that time not to continue purchasing the stock as
agreed and defaulted on the contract. BIFS notified Baldridge of the default and
gave the required ten-day notice.

Since the Baldridge default BIFS contacted some of the original Partners and
they indicated an interest in purchasing the remaining 625,000 shares to
complete the purchase and close out the 504-D.

Because of its Principals earlier involvement in purchasing stock in the 504-D,
BIFS agreed to allow Harding Asset Funds, Inc. "HAFI" and its Principals the
opportunity to purchase the remaining 625,000 shares for a reduced price because
BIFS is presently not listed on the OTC BB.

HAFI agreed to purchase, and BIFS agreed to sell the remaining 625,000 shares
for $0.50 per share.

The terms are as follows: Ten (10) equal payments of $30,000.00 each and one
payment of $12,500.00 BIFS will deliver to HAFI the stock in increments of ten
(10) 60,000 free trading share certificates upon payment to BIFS of $30,000.00
each. HAFI agrees to purchase a minimum of 60,000 shares each month for ten (10)
months and 25,000 shares on the final month. The first 60,000 shares shall be
delivered to HAFI and $30,000.00 paid to BIFS upon execution of this agreement
by both parties.

If purchaser does not make the requires payments as agreed, this agreement may
be cancelled by either party upon a ten (10) day written notice to the
defaulting party.

By execution of this agreement, both parties agree to all terms and conditions
as written above.

HARDING ASSET FUNDS, INC.                    BIOFILTRATION SYSTEMS, INC.

By: /s/ Roy Meadows                          By: /s/ Alpha Keyser
Its President                                Its President & CEO

Date: March 4, 2000                          Date: March 4, 2000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}]]